Cancer Publications 2022

23 Jun 2023
23 Jun 2023
  1.   Abdelhafeez A, Reljic T, Kumar A, Banu T, Cox S, Davidoff A, Elgendy A, Ghandour K, Gerstle J, Karpelowsky J, Kaste S. Evidence-Based Surgical Guidelines for Treating Children with Wilms Tumor in Low-Resource Settings. Authorea Preprints. 2022 Feb 18.
  2. Abrahams C, Woudberg NJ, Lecour S. Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?. Lipids in Health and Disease. 2022 Dec;21(1):1-6.
  3. Adetunji TL, Olawale F, Olisah C, Adetunji AE, Aremu AO. Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer. Frontiers in Oncology. 2022;12.
  4. Aldera AP, Pillay K, Robertson B, Boutall A, Ramesar R. Genomic landscape of colorectal carcinoma in sub-Saharan Africa. Journal of Clinical Pathology. 2022 1 September. 
  5. Antel K, Oosthuizen J, Brown K, Malherbe F, Loebenberg P, Seaton C, Baloyi S, Simba K, Chetty D, Louw VJ, Maartens G. Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis-and HIV-endemic region. AIDS (London, England). 2022 December 7th.
  6. Arowolo A, Malebana M, Sunda F, Rhoda C. Proposed Cellular Function of the Human FAM111B Protein and Dysregulation in Fibrosis and Cancer. Frontiers in oncology. 2022;12.
  7. Awotiwon OF, Cois A, Pacella R, Turawa EB, Dhansay MA, van Stuijvenberg L, Labadarios D, Roomaney RA, Neethling I, Nojilana B, Abdelatif N. Estimating the changing disease burden attributable to iron deficiency in South Africa, 2000, 2006 and 2012. South African Medical Journal. 2022 Oct 12;112(8b):684-92.
  8. Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ. Plasmablastic lymphoma: An update. International Journal of Laboratory Hematology. 2022 Sep;44:54-63.
  9. Bapiro TE, Hayeshi R, Dandara C. Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics. Frontiers in Oncology. 2022;12.
  10. Barango P. Cancer in sub-Saharan Africa: a Lancet Oncology Commission. The Lancet Oncology. 2022 May 9.
  11. Barth S, Naran K. TIM-3: a tumor-associated antigen beyond checkpoint inhibition?. Immunotherapy Advances. 2022;2(1):ltac021.
  12. Bernon MM, Gandhi K, Allam H, Singh S, Kloppers J, Jonas E. Trans-arterial therapy for Fibrolamellar carcinoma: A case report and literature review. International journal of surgery case reports. 2022 May 1;94:106980.
  13. Bhoora S, Pillay TS, Punchoo R. Cholecalciferol induces apoptosis via autocrine metabolism in epidermoid cervical cancer cells. Biochemistry and Cell Biology. 2022 Jun 20(ja).
  14. Burmeister CA, Khan SF, Schäfer G, Mbatani N, Adams T, Moodley J, Prince S. Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Research. 2022 Apr 20:200238.
  15. Calligaro GL, Singh N, Pennel TC, Steyn R, Brink A, Esmail A, Mottay L, Oelofse S, Mastrapa BL, Basera W, Manning K. Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure. EClinicalMedicine. 2023 Jan 1;55:101728.
  16. Castor D, Saidu R, Boa R, MBATANI N, Mutsvangwa TE, Moodley J, Denny LA, Kuhn L. Assessment of the implementation context in preparation for a clinical study of machine-learning algorithms to automate the classification of digital cervical images for cervical cancer screening in resource-constrained settings. Frontiers in Health Services.:81.
  17. Chambuso R, Robertson B, Ramesar R. A Scoring Model and Protocol to Adapt Universal Screening for Lynch Syndrome to Identify Germline Pathogenic Variants by Next Generation Sequencing from Colorectal Cancer Patients and Cascade Screening. Cancers. 2022 Jun 12;14(12):2901.
  18. Damerell V, Ambele MA, Salisbury S, Neumann-Mufweba A, Durandt C, Pepper MS, Prince S. The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells. Frontiers in oncology. 2021;11:801691
  19. Dar TB, Biteghe FA, Kakar-Bhanot R, Aniogo EC, Malindi Z, Akinrinmade OA, Chalomie NE, Kombe Kombe AJ, Aboughe Angone S, Ndong JM, Ndong JD. Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review. Clinical and Translational Oncology. 2022 Aug 1:1-7.
  20. Davidson A, Moodley J, Pillay K, Hendricks M, Stewart A, & Parkes J. The University of Cape Town’s paediatric cancer database: Results from the first years (2019–2021). South African Journal of Oncology,2022.
  21. Etchebehere E, Andrade R, Camacho M, Lima M, Brink A, Cerci JJ, Nadel H, Bal C, Rangarajan V, Pfluger T, Kagna O. Validation of convolutional neural network for fast determination of whole-body metabolic tumor burden in pediatric lymphoma. Journal of Nuclear Medicine Technology. 2022 Apr 1.
  22. Ezenwankwo EF, Motsoeneng P, Atterbury EM, Albertus Y, Lambert EV, Shamley D. Plausible conditions and mechanisms for increasing physical activity behavior in men with prostate cancer using patient education interventions: sequential explanatory mixed studies synthesis. Supportive Care in Cancer. 2022 Jan 21:1-7.
  23. Ezenwankwo EF, Nnaji CA, Moodley J. Cancer service delivery and the impact of the COVID-19 pandemic in sub-Saharan Africa: a scoping review ecancer 16 1485.
  24. Ezenwankwo EF, Nnate DA, Oladoyinbo CA, Dogo HM, Idowu AA, Onyeso CP, Ogo CN, Ogunsanya M, Bamidele O, Nnaji CA. Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis. Annals of Global Health. 2022;88(1).
  25. Ezenwankwo EF, Nnate DA, Usoro GD, Onyeso CP, Anieto IB, Ibeneme SC, Albertus Y, Lambert VE, Ezeukwu AO, Abaraogu UO, Shamley D. A scoping review examining the integration of exercise services in clinical oncology settings. BMC health services research. 2022 Dec;22(1):1-5.
  26. Farrant L, Harding R, Anderson D, Greeff L, Kassanjee R, Krause R, Mohamed Z, Parkes J, Gwyther L. Symptom prevalence and burden, and the risk of depression among patients with advanced cancer attending two South African oncology units. ecancermedicalscience. 2022;16.
  27. Fendler A, Shepherd ST, Au L, Wu M, Harvey R, Wilkinson KA, Schmitt AM, Tippu Z, Shum B, Farag S, Rogiers A. Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer. Cell Reports Medicine. 2022 Oct 18;3(10):100781.
  28. Firfirey F, September AV, Shamley D. ABCB1 and OPRM1 single-nucleotide polymorphisms collectively modulate chronic shoulder pain and dysfunction in South African breast cancer survivors. Pharmacogenomics. 2022 May(0).
  29. Harrison V, Khan SF, Damerell V, Bleloch J, ArulJothi KN, Sinkala M, Lennard K, Mulder N, Calder B, Blackburn J, Prince S. Strongylopus grayii tadpole blastema extract exerts cytotoxic effects on embryonal rhabdomyosarcoma cells. In Vitro Cellular & Developmental Biology-Animal. 2022 Aug 10:1-4.
  30. Horgan D, Mia R, Erhabor T, Hamdi Y, Dandara C, Lal JA, Domgue JF, Ewumi O, Nyawira T, Meyer S, Kondji D. Fighting Cancer around the World: A Framework for Action. InHealthcare 2022 October 25th (Vol. 10, No. 11, p. 2125). MDPI.
  31. Is Clinical Research Serving the Needs of the Global Cancer Burden? An analysis of contemporary global radiotherapy randomised controlled trials. Joanna Dodkins, Wilma Hopman, John Connor Wells, Yolande Lievens, R.A. Malik, C.S. Pramesh, Bishal Gyawali, Nazik Hammad, Deborah Mikherji, Richard Sullivan, Jeannette Parkes, Christopher Booth, Ajay Aggarwal. Int J Onc Biol Physics. Available online on 11 February 2022. 
  32. Iskandar R, Taghavi K, Low N, Bramer WM, Egger M, Rohner E. Mathematical Models for Evaluating Effectiveness and Cost-Effectiveness of Cervical Cancer Control Policies in Populations Including Women Living with Human Immunodeficiency Virus: A Scoping Review. Value in health regional issues. 2022 Nov 1;32:39-46.
  33. Jauquier IN, English N, Davidson A, Cox SG. Solid malignancies during the first year of life: A 20-year review at Red Cross War Memorial Children’s Hospital, Cape Town, South Africa. South African Medical Journal. 2022 Jun 1;112(6):418-25.
  34. John J, Marais B, Swanepoel P, Smit M, Comley N, Louw D. Small bowel intussusception caused by a metastatic testicular germ cell tumour. South African Journal of surgery. Suid-afrikaanse Tydskrif vir Chirurgie. 2022 Sep 1;60(3):207-9.
  35. Johnson LG, Saidu R, Svanholm-Barrie C, Boa R, Moodley J, Tergas A, Persing D, Campbell SA, Tsai WY, Wright TC, Denny L. Clinical utility of reflex testing with cancer biomarkers to improve diagnostic accuracy of primary Human Papillomavirus screening. Cancer Epidemiology and Prevention Biomarkers. 2022 Jan 1.
  36. Johnson Y, Goldberg P, Moodley J, Algar U, Thomson S, Sinanovic E, Ramesar R. A comparative cost analysis of two screening strategies for colorectal cancer in Lynch Syndrome in a South African tertiary hospital. Cancer Causes & Control. 2022 Nov 10:1-9.
  37. Jokonya L, Mduluza-Jokonya TL, Esene I, Mwale G, Thango NS, Mduluza T, Naicker T. Biochemical profile of paediatric adamantinomatous craniopharyngiomas: A prospective cohort study. Frontiers in Surgery. 2022;9.
  38. Jonas E, Bernon M, Robertson B, Kassianides C, Keli E, Asare KO, Alatise IO, Okello M, Blondel NO, Mulehane KO, Abubeker ZA. Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions. The Lancet Gastroenterology & Hepatology. 2022 8 July.
  39. Joram GO, Burger H, Visser WI, Mohamed Z. Low-dose localised electron radiotherapy in a case of refractory mycosis fungoides. South African Journal of Oncology. 2022 28 July;6:5.
  40. Khalid Z, Khan AT, Alnajjar R, Santali E, Shakoori AR. In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards COVID-19. Scientific reports. 2022 May 12;12(1):1-2.
  41. Kiwanuka M, Higgins G, Ngcobo S, Nagawa J, Lang DM, Zaman MH, Davies NH, Franz T. Effect of paclitaxel treatment on cellular mechanics and morphology of human oesophageal squamous cell carcinoma in 2D and 3D environments. Integrative Biology. 2022 Oct 21;14(6):137-49.
  42. Kriel M, Opie J, Louw V, Musekwa E, Brett S, Zelaya C. Clover leaf nuclear morphology in chronic lymphocytic leukaemia with typical immunophenotype and absence of trisomy 12. British Journal of Haematology. 2022 Apr 14.
  43. Kusza DA, Hunter R, Schäfer G, Smith M, Katz AA, Kaschula CH. Activity-Based Proteomic Identification of the S-Thiolation Targets of Ajoene in MDA-MB-231 Breast Cancer Cells. Journal of Agricultural and Food Chemistry. 2022 Nov 9.
  44. Malindi Z, Barth S, Abrahamse H. The Potential of Antibody Technology and Silver Nanoparticles for Enhancing Photodynamic Therapy for Melanoma. Biomedicines. 2022 Sep;10(9):2158.
  45. Mathers JC, Elliott F, Macrae F, Mecklin JP, Moslein G, McRonald FE, Bertario L, Evans DG, Gerdes AM, Ho JW, Lindblom A. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up. Cancer Prevention Research. 2022.
  46. Matsela LM, Cleary S, Wilkinson T. Cost utility and budget impact analysis of dexamethasone compared with bortezomib and lenalidomide for the treatment of second line multiple myeloma from a South African public health perspective. Cost Eff Resour Alloc. 2022 Dec 12;20(1):69.
  47. McAleer MF, Melchior P, Parkes J, Pater L, Rübe C, Saunders D, Paulino AC, Janssens GO, Kalapurakal J. Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors. Pediatric Blood & Cancer. 2022 Dec 8:e30090.
  48. McGinnis GJ, Ning MS, Beadle BM, Joubert N, Shaw W, Trauernich C, Simonds H, Grover S, Cardenas CE, Court LE, Smith GL. Barriers and Facilitators of Implementing Automated Radiotherapy Planning: A Multisite Survey of Low-and Middle-Income Country Radiation Oncology Providers. JCO Global Oncology. 2022 May;8:e2100431.
  49. Miguel RD, Hirata AS, Jimenez PC, Lopes LB, Costa-Lotufo LV. Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs. Pharmaceutics. 2022 Aug;14(8):1722.
  50. Moherane L, Alexander OT, Schutte-Smith M, Kroon RE, Mokolokolo PP, Biswas S, Prince S, Visser HG, Manicum AL. Polypyridyl coordinated rhenium (I) tricarbonyl complexes as model devices for cancer diagnosis and treatment. Polyhedron. 2022 December 1st;228:116178.
  51. Mohlaba GM, Adams TS, Wu HT, Mbatani NH. A case report of a patient with a primary ovarian carcinoid tumour who has right heart failure. Southern African Journal of Gynaecological Oncology. 2022 Jun 13;14(1).
  52. Mucci LA, Vinson J, Gold T, Gerke T, Filipenko J, Green RM, Anderson SG, Badal S, Bjartell A, Chi KN, Davis ID. IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer. JCO Global Oncology. 2022 Nov;8:e2200154.
  53. Muchengeti M, Bartels L, Olago V, Dhokotera T, Chen WC, Spoerri A, Rohner E, Bütikofer L, Ruffieux Y, Singh E, Egger M. Cohort profile: the South African HIV Cancer Match (SAM) Study, a national population-based cohort. BMJ open. 2022 Apr 1;12(4):e053460.
  54. Munro MG, Balen AH, Cho S, Critchley HO, Díaz I, Ferriani R, Henry L, Mocanu E, van der Spuy ZM. The FIGO ovulatory disorders classification system. Fertility and Sterility. 2022 19 August.
  55. Mutebi M, Lewison G, Aggarwal A, Alatise OI, Booth C, Cira M, Grover S, Ginsburg O, Gralow J, Gueye S, Kithaka B, Kingham TP, Kochbati L, Moodley J, Mohammed SI, Mutombo A, Ndlovu N, Ntizimira C, Parham GP, Walter F, Parkes J, Shamely D, Hammad N, Seeley J, Torode J, Sullivan R, Vanderpuye V. Cancer research across Africa: a comparative bibliometric analysis. BMJ Global Health. 2022 Nov 1;7(11):e009849.
  56. Nahvi I, Belkahla S, Biswas S, Chakraborty S. A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario. Frontiers in Oncology. 2022;12.
  57. Nahvi I, Belkahla S, Biswas S, Nahvi I, Amor B. Advances and development of prostate cancer, treatment and strategies: A systemic review. Frontiers in Cell and Developmental Biology. 2022 Sep 9:1757.
  58. Neumann-Mufweba A, Kimani S, Khan SF, Chibale K, Prince S. The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity. EXCLI journal. 2022;21:656.
  59. Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, Ali Z, Anderson BO, Anorlu R, Avery S, Cancer in sub-Saharan Africa: a Lancet Oncology Commission. 2022
  60. Nnaji CA, Ezenwankwo EF, Kuodi P, Walter FM, Moodley J. Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review. BMJ Open. 2022 Feb 1;12(2):e057685.
  61. Nnaji CA, Kuodi P, Walter FM, Moodley J. Effectiveness of interventions for improving timely diagnosis of breast and cervical cancers in low-income and middle-income countries: a systematic review. BMJ open. 2022 Apr 1;12(4):e054501.
  62. Okpara MO, Hermann C, van der Watt PJ, Garnett S, Blackburn JM, Leaner VD. A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells. Scientific Reports. 2022 Nov 23;12(1):1-4.
  63. Olivier J. Religion, cancer, and sub-Saharan African health systems. The Lancet Oncology. 2022 Jun 1;23(6):706-8.
  64. Oluwole OG, Henry M. Genomic medicine in Africa: a need for molecular genetics and pharmacogenomics experts. Current Medical Research and Opinion. 2022 Sep 12(just-accepted):1-21.
  65. Onywera H, Mabunda SA, Williamson AL, Mbulawa ZZ. Microbiological and behavioural Determinants of Genital HPV Infections among Adolescent Girls and Young Women Warrant the Need for Targeted Policy Interventions to Reduce HPV Risk. Frontiers in Reproductive Health.:56.
  66. Oodit R, Biccard BM, Panieri E, Alvarez AO, Sioson MR, Maswime S, Thomas V, Kluyts HL, Peden CJ, de Boer HD, Brindle M. Guidelines for Perioperative Care in Elective Abdominal and Pelvic Surgery at Primary and Secondary Hospitals in Low–Middle-Income Countries (LMIC’s): Enhanced Recovery After Surgery (ERAS) Society Recommendation. World Journal of Surgery. 2022 May 31:1-8.
  67. Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, Zondi N, Zungu N, Varghese C, Hunting G, Parham G. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Women's Health. 2022 Dec;22(1):1-20.
  68. Polf JC, Barajas CA, Peterson SW, Mackin DS, Beddar S, Ren L, Gobbert MK. Applications of machine learning to improve the clinical viability of Compton camera based in vivo range verification in proton radiotherapy. Frontiers in Physics. 2022:284.
  69. Prudden HJ, Achilles SL, Schocken C, Broutet N, Canfell K, Akaba H, Basu P, Bhatla N, Chirenje ZM, Delany-Moretlwe S, Denny L. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022. Vaccine. 2022 22 August
  70. Raine RI. Modern techniques for staging lung cancer–improved precision but too late for too many. African Journal of Thoracic and Critical Care Medicine. 2022;28(1).
  71. Rhee DJ, Jhingran A, Huang K, Netherton TJ, Fakie N, White I, Sherriff A, Cardenas CE, Zhang L, Prajapati S, Kry SF. Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques. Medical physics. 2022 22 July.
  72. Ruffieux Y, Muchengeti M, Olago V, Dhokotera T, Bohlius J, Egger M, Rohner E. Age and cancer incidence in 5.2 million people with HIV: the South African HIV Cancer Match study. Clinical infectious diseases. 2022 December 3rd.
  73. Saidu R, Morhason-Bello I. Same-day test and treat for early detection and treatment of cervical cancer in LMICs. The Lancet Global Health. 2022 Sep 1;10(9):e1226-7.
  74. Serala K, Steenkamp P, Mampuru L, Prince S, Poopedi K, Mbazima V. In vitro antimetastatic activity of Momordica balsamina crude acetone extract in HT29 human colon cancer cells. Environmental Toxicology. 2021 Nov;36(11):2196-205.
  75. Sharaf BM, Giddey AD, Al-Hroub HM, Menon V, Okendo J, El-Awady R, Mousa M, Almehdi A, Semreen MH, Soares NC. Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab. Cancer Chemotherapy and Pharmacology. 2022 Dec;90(6):467-88.
  76. Soares NC, Ali A, Srinivasulu V, Sharaf BM, Giddey AD, Okendo J, Al-Hroub HM, Semreen MH, Hamad M, Al-Tel TH. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach. Journal of Proteomics. 2022 15 August;265:104660.
  77. Steckelings UM, Widdop RE, Sturrock ED, Lubbe L, Hussain T, Kaschina E, Unger T, Hallberg A, Carey RM, Sumners C. The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target. Pharmacological Reviews. 2022 Oct 1;74(4):1051-135.
  78. Suzuki H, Akiyama T, Ueda N, Matsumura S, Mori M, Namiki M, Yamada N, Tsutsumi C, Tozaki S, Iwamoto H, Torii S. COVID-19 Vaccination in Patients with Cancer. Cancers. 2022 Jan;14(10):2556.
  79. Taku O, Onywera H, Mbulawa ZZ, Businge CB, Meiring TL, Williamson AL. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array. Microbiology Spectrum. 2022 Jun 1:e02229-21.
  80. Titinchi F, Sallies M, Wu HT. Mucoepidermoid carcinoma ex pleomorphic adenoma: A rare diagnostically challenging entity. Oral Oncology. 2022 Nov 1;134:106112.
  81. Trauernicht CJ, van Eeden D, du Plessis FC. Measured, calculated, and egs_brachy I125 dose distributions in a gold plaque for retinoblastoma treatment. Medical Physics. 2022 6 July.
  82. Van de Wiel HJ, Groen WG, Kampshoff CS, Buffart LM, van Mechelen W, Schep G, Sonke GS, Huijsmans R, van Harten WH, Aaronson NK, Stuiver MM. The construct validity of the Steep Ramp Test for assessing cardiorespiratory fitness in patients with breast cancer, and the impact of chemotherapy-related symptom burden. Archives of Physical Medicine and Rehabilitation. 2022 Jun 19.
  83. Van Heerden J, Irumba LC, Assani K, Downing J, Davidson A, Hessissen L, Schoeman J, Israels T, Cox S, Abdelhafeez H, Arao SO. The conference report on the 14th International Society of Paediatric Oncology African Continental Meeting, 16–18 March 2022, Kampala, Uganda.
  84. Van Heerden J, Kruger M, Esterhuizen TM, van Zyl A, Hendricks M, Cox S, Mangray H, Poole J, Naidu G, Büchner A, de Villiers M. The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting. Pediatric Hematology and Oncology. 2022 Oct 18:1-6.
  85. van Heerden J, Lisa Christine I, Downing J, Davidson A, Hessissen L, Schoeman J, Ladas EJ, Abdelhafeez H, Georgia Odongo Arao S, Fentie AM, Kamal S. Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer. Pediatric Hematology and Oncology. 2022 Aug 26:1-8.
  86. Welsh A, Mbaba M, Prince S, Smith GS. Synthesis, molecular modeling and preliminary anticancer evaluation of 2-ferrocenylbenzimidazole metallofragments. Journal of Molecular Structure. 2021 Dec 15;1246:131122